Pennant Investors, LP Enanta Pharmaceuticals Inc Call Options Transaction History
Pennant Investors, LP
- $367 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ENTA
# of Institutions
100Shares Held
21MCall Options Held
10.4KPut Options Held
2.3K-
Farallon Capital Management LLC San Francisco, CA2.1MShares$24.1 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$22.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$21.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.46MShares$16.8 Million0.0% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.25MShares$14.4 Million7.45% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $238M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...